UK reviews Palantir NHS contract ahead of 2027 break clause decision

UK reviews Palantir NHS contract ahead of 2027 break clause decision
UK reviews Palantir NHS deal

Britain is reassessing its National Health Service data platform agreement with Palantir as ministers weigh whether the contract should continue beyond its initial term. The review comes as political scrutiny intensifies over patient confidentiality, public trust and the risks of relying on a U.S. technology supplier for critical health infrastructure.

Highlights

  • The UK government is reviewing the 330 million pound, $441 million, Palantir NHS contract ahead of a potential 2027 break clause decision.
  • A parliamentary committee last week urged ministers to end the Palantir arrangement in 2027 due to data security and supplier concentration risks, despite operational benefits.
  • Political and procurement scrutiny is rising, highlighted by London Mayor Sadiq Khan blocking a 50 million pound police contract with Palantir last month over value-for-money and ethics concerns.

Contract review before 2027 decision

As reported by Reuters, technology minister Liz Kendall said on Tuesday that the government is carrying out a full review of the 330 million pound, $441 million, contract awarded to U.S. data analytics firm Palantir in 2023. The assessment is examining whether ministers should extend the NHS deal under provisions that allow it to run for as long as seven years, or use a break clause to terminate it when the initial term ends in early 2027.

Kendall told Times Radio that the health secretary is reviewing every aspect of the agreement to ensure Britain gets the right deal. The contract covers a platform designed to link NHS data, and officials must decide by early 2027 whether to continue with it.

A parliamentary committee last week urged ministers to end the arrangement at that point, arguing that Palantir's role creates an unacceptable point of weakness. The committee also warned about the risks of depending on a small group of U.S. technology companies for critical public services, even as it acknowledged reported benefits in waiting list management, operations and hospital discharge planning.

Political and procurement pressure grows

Palantir's NHS work is also attracting wider scrutiny because the company supplies software to the U.S. military and immigration authorities, and because of the political views of co-founder Peter Thiel, an early supporter of President Donald Trump. Campaigners and unions have separately raised concerns over how sensitive health data is handled within the system.

Last month, the Financial Times reported that NHS officials had proposed giving some external staff, including Palantir personnel, broad administrative access to identifiable patient data on parts of the platform. Palantir says its software helps improve patient care and efficiency across the NHS.

Neither Palantir nor NHS England immediately responds to requests for comment in the Reuters report. In a separate sign of growing procurement pressure, London Mayor Sadiq Khan last month blocked a 50 million pound police contract with Palantir, citing value-for-money concerns and questions over whether companies' ethics should be considered in public purchasing.

U.S. natural gas prices have eased after a recent rally, as updated weather forecasts point to milder temperatures later in June and therefore weaker cooling demand. Our earlier article also noted that higher production, high storage inventories, and temporary LNG export constraints are keeping near-term pressure on prices, even as summer heat and recovering LNG flows could rebalance the outlook in the second half of the year.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.
Weekly Top Bonuses
up to $2,500
deposit bonus for all clients
CLAIM BONUS
Your capital is at risk.